These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27218257)

  • 1. Cystatin C and Risk of Diabetes and the Metabolic Syndrome - Biomarker and Genotype Association Analyses.
    Magnusson M; Molvin J; Engström G; Svensson-Färbom P; Persson M; Christensson A; Nilsson P; Melander O
    PLoS One; 2016; 11(5):e0155735. PubMed ID: 27218257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C Is Not Causally Related to Coronary Artery Disease.
    Svensson-Färbom P; Almgren P; Hedblad B; Engström G; Persson M; Christensson A; Melander O
    PLoS One; 2015; 10(6):e0129269. PubMed ID: 26057752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of cystatin C predict the metabolic syndrome: the prospective Malmö Diet and Cancer Study.
    Magnusson M; Hedblad B; Engström G; Persson M; Nilsson P; Melander O
    J Intern Med; 2013 Aug; 274(2):192-9. PubMed ID: 23414447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality.
    O'Seaghdha CM; Tin A; Yang Q; Katz R; Liu Y; Harris T; Astor B; Coresh J; Fox CS; Kao WH; Shlipak MG
    Am J Kidney Dis; 2014 Jan; 63(1):16-22. PubMed ID: 23932088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort.
    Enhörning S; Bankir L; Bouby N; Struck J; Hedblad B; Persson M; Morgenthaler NG; Nilsson PM; Melander O
    Int J Obes (Lond); 2013 Apr; 37(4):598-603. PubMed ID: 22614056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-Neurotensin/Neuromedin N and Risk of Incident Metabolic Syndrome and Diabetes Mellitus in the REGARDS Cohort.
    Nicoli CD; Carson AP; Plante TB; Leann Long D; McClure LA; Schulte J; Cushman M
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3483-e3494. PubMed ID: 34013344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic vasopressin 1b receptor variance in overweight and diabetes mellitus.
    Enhörning S; Sjögren M; Hedblad B; Nilsson PM; Struck J; Melander O
    Eur J Endocrinol; 2016 Jan; 174(1):69-75. PubMed ID: 26503846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher Levels of Cystatin C in HIV/AIDS Patients with Metabolic Syndrome.
    Dragović G; Srdić D; Al Musalhi K; Soldatović I; Kušić J; Jevtović D; Nair D
    Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):396-401. PubMed ID: 29024496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of metabolic syndrome with serum cystatin C in people undergoing health examination].
    Wang Y; Cao X; Yang P; Chen M; Chen Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jul; 40(7):742-7. PubMed ID: 26267686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Cystatin C with Metabolic Syndrome and Its Prognostic Performance in Non-ST-Segment Elevation Acute Coronary Syndrome with Preserved Renal Function.
    Mao Q; Zhao N; Wang Y; Li Y; Xiang C; Li L; Zheng W; Xu S; Zhao XH
    Biomed Res Int; 2019; 2019():8541402. PubMed ID: 31317040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between HDL particle concentration and incident metabolic syndrome in the multi-ethnic Dallas Heart Study.
    Mani P; Ren HY; Neeland IJ; McGuire DK; Ayers CR; Khera A; Rohatgi A
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1(Suppl 1):S175-S179. PubMed ID: 27993539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between serum cystatin C and carotid intima-media thickness in metabolic syndrome patients with normal estimated glomerular filtration rate.
    Huang R; Gu J; Cao Q; Ma J; Gu W; Fan Z
    Clin Chim Acta; 2015 Aug; 448():170-3. PubMed ID: 26164387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of Incident Metabolic Syndrome in a Middle Eastern Population: Isfahan Cohort Study.
    Hosseini N; Talaei M; Dianatkhah M; Sadeghi M; Oveisgharan S; Sarrafzadegan N
    Metab Syndr Relat Disord; 2017 Sep; 15(7):354-362. PubMed ID: 28677982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication study reveals miR-483-5p as an important target in prevention of cardiometabolic disease.
    Gallo W; Ottosson F; Kennbäck C; Jujic A; Esguerra JLS; Eliasson L; Melander O
    BMC Cardiovasc Disord; 2021 Apr; 21(1):162. PubMed ID: 33794782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab).
    Gagnon C; Lu ZX; Magliano DJ; Dunstan DW; Shaw JE; Zimmet PZ; Sikaris K; Ebeling PR; Daly RM
    J Clin Endocrinol Metab; 2012 Jun; 97(6):1953-61. PubMed ID: 22442263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex difference in the association between creatinine-to-cystatin C ratio and metabolic syndrome among Chinese adults.
    Chen JH; Chen JY; Chen YC; Li WC
    Front Endocrinol (Lausanne); 2024; 15():1389295. PubMed ID: 39205686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between cystatin C and incident type 2 diabetes is related to central adiposity.
    Reutens AT; Bonnet F; Lantieri O; Roussel R; Balkau B;
    Nephrol Dial Transplant; 2013 Jul; 28(7):1820-9. PubMed ID: 23291367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-483-5p associates with obesity and insulin resistance and independently associates with new onset diabetes mellitus and cardiovascular disease.
    Gallo W; Esguerra JLS; Eliasson L; Melander O
    PLoS One; 2018; 13(11):e0206974. PubMed ID: 30408096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and the plasma proteome: from association to causation.
    Elhadad MA; Wilson R; Zaghlool SB; Huth C; Gieger C; Grallert H; Graumann J; Rathmann W; Koenig W; Sinner MF; Hveem K; Suhre K; Thorand B; Jonasson C; Waldenberger M; Peters A
    Cardiovasc Diabetol; 2021 May; 20(1):111. PubMed ID: 34016094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of rs6921438 AGhazizadeh H; Avan A; Fazilati M; Azimi-Nezhad M; Tayefi M; Ghasemi F; Mehramiz M; Moohebati M; Ebrahimi M; Mirhafez SR; Ferns GA; Esmaeili H; Pasdar A; Ghayour-Mobarhan M
    Gene; 2018 Aug; 667():70-75. PubMed ID: 29733969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.